LifeStance Health Group (LFST) Revenue & Revenue Breakdown
LifeStance Health Group Revenue Highlights
Latest Revenue (Y)
$1.06B
Latest Revenue (Q)
$300.44M
LifeStance Health Group Revenue by Period
LifeStance Health Group Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.06B | 22.82% |
| 2022-12-31 | $859.54M | 28.77% |
| 2021-12-31 | $667.51M | 76.96% |
| 2020-12-31 | $377.22M | 77.50% |
| 2019-12-31 | $212.52M | - |
LifeStance Health Group generated $1.06B in revenue during NA 2023, up 22.82% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
LifeStance Health Group Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $300.44M | 7.07% |
| 2023-12-31 | $280.60M | 6.74% |
| 2023-09-30 | $262.89M | 1.28% |
| 2023-06-30 | $259.58M | 2.77% |
| 2023-03-31 | $252.59M | 10.13% |
| 2022-12-31 | $229.36M | 5.42% |
| 2022-09-30 | $217.56M | 3.83% |
| 2022-06-30 | $209.53M | 3.17% |
| 2022-03-31 | $203.09M | 6.89% |
| 2021-12-31 | $190.00M | 9.30% |
| 2021-09-30 | $173.84M | 8.28% |
| 2021-06-30 | $160.55M | 12.17% |
| 2021-03-31 | $143.13M | 21.17% |
| 2020-12-31 | $118.12M | 15.83% |
| 2020-09-30 | $101.98M | 124.37% |
| 2020-06-30 | $45.45M | -37.83% |
| 2020-03-31 | $73.11M | - |
LifeStance Health Group generated $300.44M in revenue during Q1 2024, up 7.07% compared to the previous quarter, and up 130.99% compared to the same period a year ago.
LifeStance Health Group Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| UHS | Universal Health Services | $14.28B | $3.91B |
| SEM | Select Medical | $6.66B | $1.76B |
| EHC | Encompass Health | $4.80B | $1.30B |
| ENSG | Ensign Group | $3.73B | $1.04B |
| ACHC | Acadia Healthcare | $2.93B | $796.04M |
| MODV | ModivCare | $2.75B | $698.30M |
| SGRY | Surgery Partners | $2.74B | $762.10M |
| AMEH | Astrana Health | $1.14B | $348.17M |
| ADUS | Addus HomeCare | $1.06B | $286.92M |
| LFST | LifeStance Health Group | $1.06B | $300.44M |
| EHAB | Enhabit | $1.05B | $260.60M |
| INNV | InnovAge | $688.09M | $193.07M |
| PNTG | Pennant Group | $544.89M | $156.91M |
| CCM | Concord Medical Services | $537.40M | $34.94M |
LFST Revenue FAQ
What is LifeStance Health Group’s yearly revenue?
LifeStance Health Group's yearly revenue for 2023 was $1.06B, representing an increase of 22.82% compared to 2022. The company's yearly revenue for 2022 was $859.54M, representing an increase of 28.77% compared to 2021. LFST's yearly revenue for 2021 was $667.51M, representing an increase of 76.96% compared to 2020.
What is LifeStance Health Group’s quarterly revenue?
LifeStance Health Group's quarterly revenue for Q1 2024 was $300.44M, a 7.07% increase from the previous quarter (Q4 2023), and a 18.94% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $280.6M, a 6.74% increase from the previous quarter (Q3 2023), and a 22.34% increase year-over-year (Q4 2022). LFST's quarterly revenue for Q3 2023 was $262.9M, a 1.28% increase from the previous quarter (Q2 2023), and a 20.84% increase year-over-year (Q3 2022).
What is LifeStance Health Group’s revenue growth rate?
LifeStance Health Group's revenue growth rate for the last 3 years (2021-2023) was 58.15%, and for the last 5 years (2019-2023) was 396.74%.